These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
595 related items for PubMed ID: 16328181
1. [Hypertension and diabetic nephropathy, a dangerous duo]. Hausberg M, Hohage H, Kosch M. Med Klin (Munich); 2005 Nov 15; 100(11):729-37; quiz 738-9. PubMed ID: 16328181 [No Abstract] [Full Text] [Related]
2. [Antihypertensive treatment in the type 2 diabetic]. Fournier A. Nephrologie; 2000 Nov 15; 21(4):203-4. PubMed ID: 10976435 [No Abstract] [Full Text] [Related]
3. [Prediction, screening and treatment of renal complications of diabetes]. Marre M, Larger E. Rev Prat; 2001 Oct 15; 51(16):1769-75. PubMed ID: 11795120 [Abstract] [Full Text] [Related]
4. Exforge HCT. Med Lett Drugs Ther; 2009 Jun 15; 51(1314):47. PubMed ID: 19528888 [No Abstract] [Full Text] [Related]
5. [Control of arterial pressure in diabetic nephropathy]. Luño J, García de Vinuesa S. Nefrologia; 2001 Jun 15; 21(3):240-5. PubMed ID: 11471304 [No Abstract] [Full Text] [Related]
6. Angiotensin receptor blockers and myocardial infarction: the importance of dosage. Sarzani R, Dessì-Fulgheri P. J Hypertens; 2006 Aug 15; 24(8):1679-81; author reply 1681-2. PubMed ID: 16877973 [No Abstract] [Full Text] [Related]
7. Diabetic nephropathy in non-insulin dependent diabetes mellitus. Cardiovascular risk factors and antihypertensive treatment. Nielsen FS. Dan Med Bull; 2000 Sep 15; 47(4):249-70. PubMed ID: 11064829 [No Abstract] [Full Text] [Related]
8. [Treatment recommendations for various stages in diabetic nephropathy]. Takane H, Suzuki H. Nihon Rinsho; 2005 Jun 15; 63 Suppl 6():379-83. PubMed ID: 15999738 [No Abstract] [Full Text] [Related]
9. [In the DETAIL. Kidney protection in manifestations of microalbuminuria]. MMW Fortschr Med; 2006 Jun 29; 148(26):51. PubMed ID: 16875382 [No Abstract] [Full Text] [Related]
10. [In the framework of the 72nd Annual Meeting of the DKG (German CardiologySociety) in Mannheim presented: Ontarget-the until now largest study program on cardiovascular prevention in patients with hypertension]. MMW Fortschr Med; 2006 Jun 29; 148(26):50-1. PubMed ID: 16875381 [No Abstract] [Full Text] [Related]
11. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent]. MMW Fortschr Med; 2003 Dec 04; 145(49):18-9. PubMed ID: 14963986 [No Abstract] [Full Text] [Related]
12. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine. Ferri C, Croce G, Desideri G. Adv Ther; 2008 Apr 04; 25(4):300-20. PubMed ID: 18449492 [Abstract] [Full Text] [Related]
13. [First fixed combination of sartan and high-dosage diuretic. A strong duo against high blood pressure]. MMW Fortschr Med; 2004 Apr 01; 146(14):45. PubMed ID: 15344757 [No Abstract] [Full Text] [Related]
14. [Angiotensin II receptor blockers--evidence along the cardiovascular continuum]. Zeller A, Battegay E. Praxis (Bern 1994); 2005 Apr 13; 94(15):581-94. PubMed ID: 15884724 [Abstract] [Full Text] [Related]
15. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases]. Baumgart P. MMW Fortschr Med; 2006 Mar 16; 148(11):57, 59-60. PubMed ID: 16612965 [No Abstract] [Full Text] [Related]
16. [Risk oriented therapy of hypertension. Lowering blood pressure and risk]. MMW Fortschr Med; 2007 Nov 15; 149(46):53. PubMed ID: 18069196 [No Abstract] [Full Text] [Related]
17. [Renoprotective effects of ACE inhibitors and AT1 antagonists on diabetic nephropathy beyond blood pressure control]. Shionoiri H, Yasuda G, Takizawa T, Shionoiri F. Nihon Rinsho; 2005 Jun 15; 63 Suppl 6():394-9. PubMed ID: 15999741 [No Abstract] [Full Text] [Related]
18. [VALUE study underscores the importance of reaching goal blood pressure values for minimization of cardiovascular risks]. Praxis (Bern 1994); 2004 Oct 27; 93(44):1836. PubMed ID: 15559910 [No Abstract] [Full Text] [Related]
19. Clinical practice. Nephropathy in patients with type 2 diabetes. Remuzzi G, Schieppati A, Ruggenenti P. N Engl J Med; 2002 Apr 11; 346(15):1145-51. PubMed ID: 11948275 [No Abstract] [Full Text] [Related]